<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> are progressive diseases associated with a high risk of complications over time including strictures, fistulae, perianal complications, surgery, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Changing the natural history and avoiding evolution to a <z:e sem="disease" ids="C0596452" disease_type="Disease or Syndrome" abbrv="">disabling disease</z:e> should be the main goal of treatment </plain></SENT>
<SENT sid="2" pm="."><plain>In recent studies, mucosal healing has been associated with longer-term remission and fewer complications </plain></SENT>
<SENT sid="3" pm="."><plain>Conventional therapies with immunosuppressive drugs are able to induce mucosal healing in a minority of cases but their impact on disease progression appears modest </plain></SENT>
<SENT sid="4" pm="."><plain>Higher rates of mucosal healing can be achieved with anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor therapies that reduce the risk of relapse, surgery and hospitalization, and are associated with perianal fistulae closure </plain></SENT>
<SENT sid="5" pm="."><plain>These drugs might be able to change the natural history of the disease mainly when introduced early in the course of the disease </plain></SENT>
<SENT sid="6" pm="."><plain>Treatment strategy in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e> should thus be tailored according to the risk that each patient could develop <z:e sem="disease" ids="C0596452" disease_type="Disease or Syndrome" abbrv="">disabling disease</z:e> </plain></SENT>
</text></document>